Dr. Reddy's Laboratories Limited (RDY)
NYSE: RDY · Real-Time Price · USD
13.89
+0.61 (4.59%)
Jan 22, 2026, 1:24 PM EST - Market open
Dr. Reddy's Laboratories Market Cap
Dr. Reddy's Laboratories has a market cap or net worth of $11.06 billion as of January 22, 2026. Its market cap has decreased by -15.35% in one year.
Market Cap
11.06B
Enterprise Value
10.98B
1-Year Change
-15.35%
Ranking
Category
Stock Price
$13.89
Market Cap Chart
Since April 11, 2001, Dr. Reddy's Laboratories's market cap has increased from $839.80M to $11.06B, an increase of 1,217.43%. That is a compound annual growth rate of 10.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 10.80B | -7.83% |
| Dec 31, 2025 | 11.72B | -11.04% |
| Dec 31, 2024 | 13.17B | 13.66% |
| Dec 29, 2023 | 11.59B | 34.54% |
| Dec 30, 2022 | 8.61B | -20.82% |
| Dec 31, 2021 | 10.88B | -8.18% |
| Dec 31, 2020 | 11.85B | 75.79% |
| Dec 31, 2019 | 6.74B | 7.74% |
| Dec 31, 2018 | 6.25B | 0.47% |
| Dec 29, 2017 | 6.23B | -19.41% |
| Dec 30, 2016 | 7.73B | -2.05% |
| Dec 31, 2015 | 7.89B | -8.10% |
| Dec 31, 2014 | 8.58B | 23.16% |
| Dec 31, 2013 | 6.97B | 23.45% |
| Dec 31, 2012 | 5.64B | 13.32% |
| Dec 30, 2011 | 4.98B | -20.18% |
| Dec 31, 2010 | 6.24B | 53.01% |
| Dec 31, 2009 | 4.08B | 147.47% |
| Dec 31, 2008 | 1.65B | -45.95% |
| Dec 31, 2007 | 3.05B | 9.23% |
| Dec 29, 2006 | 2.79B | 68.91% |
| Dec 30, 2005 | 1.65B | 8.92% |
| Dec 31, 2004 | 1.52B | -37.34% |
| Dec 31, 2003 | 2.42B | 50.67% |
| Dec 31, 2002 | 1.61B | 2.01% |
View and export this data all the way back to 2001. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| United Therapeutics | 20.23B |
| Viatris | 15.03B |
| Neurocrine Biosciences | 13.50B |
| Elanco Animal Health | 12.07B |
| Regencell Bioscience Holdings | 10.83B |
| Hims & Hers Health | 6.58B |
| Alkermes | 5.59B |
| Lantheus Holdings | 4.41B |